105 related articles for article (PubMed ID: 1502486)
1. Effects of acute pancreatitis on hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility: protective effects of a new synthetic protease inhibitor, ONO 3307.
Hirano T; Manabe T; Calne R; Tobe T
Scand J Gastroenterol; 1992; 27(3):227-32. PubMed ID: 1502486
[TBL] [Abstract][Full Text] [Related]
2. Impaired hepatic energy metabolism in rat acute pancreatitis: protective effects of prostaglandin E2 and synthetic protease inhibitor ONO 3307.
Hirano T; Manabe T; Tobe T
J Surg Res; 1992 Sep; 53(3):238-44. PubMed ID: 1528049
[TBL] [Abstract][Full Text] [Related]
3. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
Hirano T; Manabe T; Tobe T
Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
[TBL] [Abstract][Full Text] [Related]
4. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Hirano T; Manabe T; Tobe T
Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic perturbation of rat liver lysosomes: effects on release of lysosomal enzymes and of lipids into bile.
Sewell RB; Grinpukel SA; Zinsmeister AR; LaRusso NF
Gastroenterology; 1988 Oct; 95(4):1088-98. PubMed ID: 3137115
[TBL] [Abstract][Full Text] [Related]
7. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076
[TBL] [Abstract][Full Text] [Related]
8. Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats.
Sata N; Atomi Y; Kimura W; Kuroda A; Muto T; Mineo C
Int J Pancreatol; 1994 Apr; 15(2):119-27. PubMed ID: 8071570
[TBL] [Abstract][Full Text] [Related]
9. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
Hirano T; Manabe T
J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
[TBL] [Abstract][Full Text] [Related]
10. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of omeprazole, a potent inhibitor of gastric (H+ + K+) ATPase, on hepatic lysosomal integrity and enzyme activity.
Grinpukel S; Sewell R; Yeomans N; Mihaly G; Smallwood R
J Pharm Pharmacol; 1986 Feb; 38(2):158-60. PubMed ID: 2870166
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats.
Hirano T; Manabe T; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):224-33. PubMed ID: 1444702
[TBL] [Abstract][Full Text] [Related]
13. Ethanol impairs biliary lysosomal enzyme release in rats.
Sewell RB; Grinpukel SA; Yeomans ND
Clin Exp Pharmacol Physiol; 1986 Oct; 13(10):745-50. PubMed ID: 3802579
[TBL] [Abstract][Full Text] [Related]
14. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307].
Hirano T; Yotsumoto TM; Ando K; Tobe T
Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453
[TBL] [Abstract][Full Text] [Related]
15. Effects of rabeprazole, a gastric proton pump inhibitor, on biliary and hepatic lysosomal enzymes in rats.
Fujisaki H; Oketani K; Nagakawa J; Takenaka O; Yamanishi Y
Jpn J Pharmacol; 1998 Mar; 76(3):279-88. PubMed ID: 9593221
[TBL] [Abstract][Full Text] [Related]
16. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate].
Hirano T; Manabe T; Tobe T
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.
Satake K; Ha SS; Hiura A; Nishiwaki H
Gastroenterol Jpn; 1993 Feb; 28(1):64-71. PubMed ID: 8440425
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis.
Hirano T; Manabe T; Imanishi K; Tobe T
J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
[TBL] [Abstract][Full Text] [Related]
20. The lysosomal hydrolases in the rat pancreas after maximal or supramaximal stimulation with cerulein.
Baniukiewicz AA; Dlugosz JW; Gabryelewicz A
Int J Pancreatol; 1994 Aug; 16(1):71-9. PubMed ID: 7806914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
